Order Article Reprints

Mancusi A, Zorutti F, Ruggeri L, Bonato S, Tricarico S, Zei T, Iacucci Ostini R, Viglione V, Sembenico R, Sciabolacci S, et al. Blinatumomab Redirects Donor Lymphocytes against CD19⁺ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences. 2023; 24(22):16105. https://doi.org/10.3390/ijms242216105

Mancusi, Antonella, Francesco Zorutti, Loredana Ruggeri, Samanta Bonato, Sara Tricarico, Tiziana Zei, Roberta Iacucci Ostini, Valerio Viglione, Rebecca Sembenico, Sofia Sciabolacci, and et al. 2023. "Blinatumomab Redirects Donor Lymphocytes against CD19⁺ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation" International Journal of Molecular Sciences 24, no. 22: 16105. https://doi.org/10.3390/ijms242216105

Mancusi, A., Zorutti, F., Ruggeri, L., Bonato, S., Tricarico, S., Zei, T., Iacucci Ostini, R., Viglione, V., Sembenico, R., Sciabolacci, S., Cardinali, V., Martelli, M. F., Mecucci, C., Carotti, A., Martelli, M. P., Velardi, A., & Pierini, A. (2023). Blinatumomab Redirects Donor Lymphocytes against CD19⁺ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences, 24(22), 16105. https://doi.org/10.3390/ijms242216105